UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ___________________________________ FORM 10-Q ___________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-4304 ___________________________________ COMMERCIAL METALS COMPANY ...

In the first quarter we completed the delivery of the remaining finished lots in Phase 2C and closed on the initial plat payment with a new homebuilder partner in Phase 2D. Our national homebuilder partners have already begun construction in Phase 2C. We expect to complete Phase 2D in fiscal 2026. Pure Cycle continues to diversify our land development segment by partnering with two new national homebuilders in Phase 2D to bring our portfolio of homebuilders to seven national builders. Finally, we have start ...

Exhibit 99.1 NEWS RELEASE Contacts: Main Street Capital Corporation Dwayne L. Hyzak, CEO, dhyzak@mainstcapital.com Ryan R. Nelson, CFO, rnelson@mainstcapital.com 713-350-6000 Dennard Lascar Investor Relations Ken Dennard / ken@dennardlascar.com Zach Vaughan / zvaughan@dennardlascar.com 713-529-6600 Main Street Announces Fourth Quarter 2025 Private Loan Portfolio Activity HOUSTON – January 8, 2026 – Main Street Capital Corporation (NYSE: MAIN) ("Main Street") is pleased to announce the following recent activ ...

LOGO Exhibit 10.3 EMPLOYMENT AGREEMENT This Employment Agreement ("Agreement") is made between Tango Therapeutics, Inc., a Delaware corporation (the "Company"), and Malte Peters, M.D. (the "Executive"), and is effective as of the Effective Date, as defined in Section 23 herein. WHEREAS, the Company desires to employ the Executive and the Executive desires to be employed by the Company on the new terms and conditions contained herein. NOW, THEREFORE, in consideration of the mutual covenants and agreements he ...

LOGO Exhibit 99.1 During the presentation, Atea will provide an update on the progress of its global Phase 3 program evaluating the potential best-in-class regimen of bemnifosbuvir (BEM) and ruzasvir (RZR) for the treatment of Hepatitis C virus (HCV). The Company will also detail challenges with current HCV therapeutics and the potential of Atea's regimen to meaningfully address them. In addition, the Company will discuss opportunities to expand HCV treatment through further adoption of the test-and-treat m ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2026 ASTRONICS CORPORATION (Exact name of registrant as specified in its charter) New York 0-7087 16-0959303 (State of Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 130 Commerce Way East Aurora, New York 14052 (Address of principal ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 CURRENT REPORT GOLUB CAPITAL BDC, INC. Delaware 814-00794 27-2326940 (State or Other Jurisdiction of Incorporation) Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 8, 2026 FORM 8-K (Exact name of Registrant as Specified in Its Charter) (Commission File Number) (IRS Employer Identification No.) __ 200 Park Avenue, 25th Floor, New York, NY 10166_ _ (Address of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 6, 2026 Xilio Therapeutics, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-40925 85-1623397 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 828 Winter Street, Suite 300 Waltham, Massachusetts 02451 (Address ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2026 Image_0.jp ARDELYX, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) (Commission File Number) Delaware 001-36485 26-1303944 (IRS Employer Identification Number) 400 FIFTH AVE., SUITE 210, WALTHAM, MASSACHUSETTS 02451 (Add ...

slide l fi w w w.n e w t e k o n e.c o m N A S D A Q: N E W T I n v e s t o r D a y 2 0 2 6 J a n u a ry 8 , 2 0 2 6 H o s t e d a n d P r e s e n t e d b y: B a rry S l o a n e , C h a i r m a n , P r e s i d e n t & C E O F r a n k M. D e M a r i a , E V P & C h i e f F i n a n c i a l O ffi c e r P e t e r D o w n s , P r e s i d e n t , N e w t e k B a n k , N.A. A n d r e w K ap l a n , C h i e f S t r a t e g y O ffi c e r I n v e s t o r R e l a t i o n s B ry c e R o w e b r o w e @ n e w t e k o n ...